BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB

SOL #: CBRND-BAA-22-01Solicitation

Overview

Buyer

DEPT OF DEFENSE
Dept Of The Army
W6QK ACC-APG
ABERDEEN PROVING GROU, MD, 21010-5424, United States

Place of Performance

Frederick, MD

NAICS

Research and Development in the Physical (541715)

PSC

National Defense R&D Services; Department Of Defense Military; Applied Research (AC12)

Set Aside

No set aside specified

Timeline

1
Posted
Jun 11, 2022
2
Last Updated
May 26, 2023
3
Submission Deadline
Jun 11, 2027, 4:00 AM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of the Army has issued a Broad Agency Announcement (BAA) for Research and Development in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), specifically for Joint Project Manager Medical (JPM Medical) and Joint Product Lead Enabling Biotechnologies (JPL CBRND EB). This BAA seeks innovative science for developing medical countermeasures and enabling biotechnologies. Pre-proposals can be submitted at any time until June 11, 2027.

Scope of Work

This BAA focuses on developing medical CBRN countermeasures and enabling biotechnologies. Specific interest areas include novel solutions and improved methods for rapid and efficient medical countermeasure development through enabling technologies, life cycle bioinformatics, and improved logistics tracking. Proposals based on data from experiments using specific CBRN warfare agents to demonstrate safety, efficacy, or mode of action are not of interest. Advanced development efforts should generally be limited to Technology Readiness Level (TRL) 4.

Contract & Timeline

  • Type: Broad Agency Announcement (BAA) contemplating Procurement Contracts, Grants, Cooperative Agreements, Technology Investment Agreements (TIAs), and Other Transaction Agreements (OTAs).
  • Duration: Open for submissions until June 11, 2027.
  • Set-Aside: None (open to all eligible sources).
  • Published: May 26, 2023.
  • Pre-proposal Due: Ongoing until June 11, 2027.

Submission & Evaluation

  • Submission: Offerors are encouraged to submit unsolicited pre-proposals (white papers) at any time while the BAA is active. Full proposals will be requested if a pre-proposal is accepted.
  • Evaluation Factors: Technical Merit, Military and Program Relevance, Funds Availability, Technology Readiness Level (TRL), Project Objectives, Regulatory Compliance, Support of other U.S. Government requirements, Key Personnel Qualifications, Facilities, Budget/Cost, and Past Performance.
  • Award Decisions: Expected within 180 days after submission.

Eligibility

Open to all eligible sources, including educational institutions, nonprofit organizations, and private industry.

Additional Notes

  • All questions and white paper submissions should be sent to usarmy.detrick.dod-jpeo-cbrnd.mbx.baa@army.mil.
  • Potential offerors are encouraged to discuss proposal ideas with JPMO technical contacts listed in Section VII (B) of the BAA.
  • The BAA is available on Grants.gov, SAM.gov, and the JPEO-CBD website.

People

Points of Contact

Files

Files

Download

Versions

Version 2Viewing
Solicitation
Posted: May 26, 2023
Version 1
Solicitation
Posted: Jun 11, 2022
View
BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB | GovScope